{"disease":{"id":"egfr-mutated-locally-advanced-or-metastatic-nsclc","name":"egfr mutated locally advanced or metastatic nsclc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06927986","title":"Phase III Trial of SYS6010 Versus Platinum-based Chemotherapy for EGFR-mutated NSCLC（SYNSTAR01）","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":380,"lead_sponsor_name":"CSPC Megalith Biopharmaceutical Co.,Ltd.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}